Clinical Trials in the Community Setting

Clinical trials represent the forefront of our knowledge in cancer care. Patients participating in these trials are receiving the best of the best in cancer treatment – and advancing our ability to fight cancer in the future. The popular perception is that clinical trials are limited to university or hospital systems, but this couldn’t be further from the truth. At community oncology clinics around the nation, clinicians and patients are breaking ground in the fight against cancer with cutting edge clinical trials.

On May 12 at 12 p.m. ET, Katie Goodman, Vice President, Clinical Research, American Oncology Network (AON) and Rose Gerber, Director of Patient Advocacy & Education, COA, shared information from the provider and patient perspective on clinical trials, including understanding the different types of clinical trials, the rigorous safety review process, and who is eligible to take part in a trial (hint: just about anybody!). From contributing to advancements in care for patients to expanding one’s health outcomes, clinical trials provide opportunities for patients to make an impact on their own health care and on the lives of others going forward.

CPAN Advocacy Chats are regular virtual 30-minute educational conversations about cancer advocacy and policy with a guest speaker invited to discuss issues important to patients and advocates. Summaries of previous Advocacy Chats are available on the CPAN website.

  • Upcoming Advocacy Chat
    Pharmacy Benefit Managers: What Patients Need to Know

    May 15, 2024 12:00 pm

    Join the Community Oncology Alliance Patient Advocacy Network (CPAN) for a virtual Advocacy Chat on Wednesday, May 15, at 12 p.m. ET about the impact of pharmacy benefit managers (PBMs) on patient care and what patients need to know when interacting with PBMs.